Gemcitabine Plus Carboplatin Versus Mitomycin, Ifosfamide, and Cisplatin in Patients With Stage IIIB or IV Non-Small-Cell Lung Cancer: A Phase III Randomized Study of the London Lung Cancer Group - Concepedia

Concepedia

Publication | Open Access

Gemcitabine Plus Carboplatin Versus Mitomycin, Ifosfamide, and Cisplatin in Patients With Stage IIIB or IV Non-Small-Cell Lung Cancer: A Phase III Randomized Study of the London Lung Cancer Group

DOI Full Paper Access

157

Citations

22

References

2004

Year

R.M. Rudd, N.H. Gower, Stephen Spiro, Tim Eisen, Peter Harper, J.A.H. Littler, M. Hatton, Peter Johnson, William McChesney Martin, Elaine M. Rankin,

Journal of Clinical Oncology

Abstract

In patients with advanced NSCLC, GCa chemotherapy was shown to be a better-tolerated treatment that conferred a survival advantage over MIC.

References

	Year	Citations

Page 1